SEC Form 4 · accession 0001013762-15-000067
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Bacha
Officer — CEO and President · Director
Period of report
Jan 22, 2015
Accepted (ET)
Jan 22, 2015 · 12:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2015 | P | 5,000 | $0.66 | A | 60,985 | D | |
| Common Stock | Jan 22, 2015 | P | 2,500 | $0.65 | A | 63,485 | D |
Table II — derivative securities
No Table II lines on this filing.